Search results for "Gastrin"

showing 10 items of 46 documents

The Daily Consumption of Cola Can Determine Hypocalcemia: A Case Report of Postsurgical Hypoparathyroidism-Related Hypocalcemia Refractory to Supplem…

2017

The consumption of soft drinks is a crucial factor in determining persistent hypocalcemia. The aim of the study was to evaluate the biochemical mechanisms inducing hypocalcemia in a female patient with usual high consumption of cola drink and persistent hypocalcemia, who failed to respond to high doses of calcium and calcitriol supplementation. At baseline and after pentagastrin injection, gastric and duodenal secretion samples were collected and calcium and total phosphorus concentrations were evaluated. At the same time, blood calcium, total phosphorus, sodium, potassium, chloride, magnesium concentrations and vitamin D were sampled. After intake of cola (1 L) over 180 min, gastric and du…

0301 basic medicinemedicine.medical_specialtyCalcitriolEndocrinology Diabetes and MetabolismSodiumPotassiumchemistry.chemical_elementCase Report030209 endocrinology & metabolismCalciumhypocalcemiacalcium absorption; cola; hyperphosphatemia; hypocalcemia; hypoparathyroidismCola (plant)calcium absorptionSettore MED/13 - Endocrinologia03 medical and health sciencesEndocrinology0302 clinical medicinehypocalcemia cola hypoparathyroidism hyperphosphatemia calcium absorptionInternal medicinemedicinehyperphosphatemiaSettore CHIM/02 - Chimica FisicaCalcium metabolismbiologyChemistryhypoparathyroidismcolaSettore CHIM/06 - Chimica Organicamedicine.diseasebiology.organism_classificationSettore MED/45 - Scienze Infermieristiche Generali Cliniche E PediatrichePentagastrin030104 developmental biologyEndocrinologyHypoparathyroidismmedicine.drug
researchProduct

MEN1 Disease Occurring Before 21 Years Old: A 160-Patient Cohort Study From the Groupe d'étude des Tumeurs Endocrines

2015

Multiple endocrine neoplasia Type-1 (MEN1) in young patients is only described by case reports.To improve the knowledge of MEN1 natural history before 21 years old.Obtain a description of the first symptoms occurring before 21 years old (clinical symptoms, biological or imaging abnormalities), surgical outcomes related to MEN1 Neuro Endocrine Tumors (NETs) occurring in a group of 160 patients extracted from the "Groupe d'étude des Tumeurs Endocrines" MEN1 cohort.The first symptoms were related to hyperparathyroidism in 122 cases (75%), pituitary adenoma in 55 cases (34%), nonsecreting pancreatic tumor (NSPT) in 14 cases (9%), insulinoma in 20 cases (12%), gastrinoma in three cases (2%), mal…

AdenomaAdultMalemedicine.medical_specialtyAdolescentendocrine system diseasesAdenomaEndocrinology Diabetes and MetabolismClinical BiochemistryAdrenal Gland NeoplasmsContext (language use)BiochemistryCohort StudiesYoung AdultEndocrinologyPancreatic tumorPituitary adenomaInternal medicineMultiple Endocrine Neoplasia Type 1medicineHumansPituitary NeoplasmsAge of OnsetChildMultiple endocrine neoplasiaGastrinomabusiness.industryBiochemistry (medical)Infantmedicine.diseasePancreatic NeoplasmsNeuroendocrine TumorsEndocrinologyChild PreschoolFemaleInsulinomaFranceAge of onsetbusinessCohort studyThe Journal of Clinical Endocrinology & Metabolism
researchProduct

Lack of plasmic beta-endorphin response to a gastronomic meal in healthy humans.

1991

Abstract In order to study the relationship between the endogenous opiate system and food intake in man, plasma concentrations of beta-endorphin were measured in ten healthy subjects. Time course of beta-endorphinemia was compared under the following conditions: basal (fasting), after an injection of pentagastrin (6 μg/kg), or after a gastronomic meal. No changes in plasma beta-endorphin or ACTH concentrations were observed with pentagastrin nor after the meal, despite the combination of very high sensory pleasure with intake of a very large amount of food. It is concluded that blood beta-endorphin concentration is not a sensitive index of the effects of food intake on the endogenous opioid…

AdultBlood GlucoseMaleendocrine systemmedicine.medical_specialtyHungerAppetiteExperimental and Cognitive PsychologyPeptide hormoneBehavioral Neurosciencechemistry.chemical_compoundEatingInternal medicinemedicineHumansPalatabilityEndogenous opioidMealbusiness.industrydigestive oral and skin physiologybeta-EndorphinPentagastrinAffectEndocrinologychemistryBasal (medicine)TasteReceptors Opioidbeta-EndorphinOpiatebusinessArousalEnergy Intakehormones hormone substitutes and hormone antagonistsmedicine.drugPhysiologybehavior
researchProduct

Abnormal pentagastrin response in a patient with pseudohypoparathyroidism

2002

The case of a 25 year old female patient with pseudohypoparathyroidism type I (PHP) and hypercalcitoninaemia is reported. She was referred to our clinic because of recurrent hypocalcaemia associated with paraesthesias and muscle cramps. She had no signs of Albright hereditary osteodystrophy (AHO), a normal mental status and no family history of hypocalcaemia or any other endocrine disease. Considering the laboratory results with hypocalcaemia, hyperphosphataemia, normal vitamin D and normal creatinine with an extraordinary elevated PTH we diagnosed pseudohypoparathyroidism type I. She had delayed pubertal development with menarche in the age of 20 and hypothyroidism with an atrophic thyroid…

AdultCalcitoninmusculoskeletal diseasesmedicine.medical_specialtyendocrine system diseasesEndocrinology Diabetes and MetabolismGastroenterologyPhosphatesEndocrinologyHypothyroidismInternal medicineInternal MedicinemedicineHumansHypocalcaemiaFamily historyPseudohypoparathyroidismPuberty DelayedEndocrine diseaseHypocalcemiabusiness.industryThyroidGeneral MedicineAlkaline Phosphatasemedicine.diseasePentagastrinmedicine.anatomical_structureEndocrinologyCalcitoninPseudohypoparathyroidismCalciumFemalePentagastrinmedicine.symptombusinessMuscle crampmedicine.drugExperimental and Clinical Endocrinology & Diabetes
researchProduct

Gastric plasma biomarkers and Operative Link for Gastritis Assessment gastritis stage

2011

Introduction The Operative Link for Gastritis Assessment (OLGA) staging system has been proposed as a histopathological reporting system of gastric atrophy. Noninvasive methods for indirect evaluation of gastric mucosal atrophy by biomarkers are also being introduced. Objectives To analyze gastric mucosal atrophy by biomarkers, pepsinogen I (PgI), pepsinogen II (PgII), PgI/PgII ratio, fasting gastrin-17 (G-17), stimulated gastrin-17 (sG-17), in relation to OLGA gastritis stage. Patients and methods Gastric biopsies were taken from 269 prospective patients referred for upper endoscopy because of dyspeptic problems and evaluated by two expert pathologists (D.J. and P.S.). Atrophy was assessed…

AdultGastritis AtrophicMalemedicine.medical_specialtyStage iiPlasma biomarkersGastroenterologyHelicobacter InfectionsAtrophyPepsinogen AInternal medicineGastrinsPepsinogen CHumansMedicineProspective StudiesStage (cooking)Prospective cohort studyAgedAged 80 and overHelicobacter pyloriHepatologybusiness.industryGeneral surgeryGastroenterologyMiddle Agedmedicine.diseaseFemaleGastritismedicine.symptombusinessGastric mucosal atrophyReporting systemBiomarkersEuropean Journal of Gastroenterology & Hepatology
researchProduct

Chromogranin Serves as Novel Biomarker of Endocrine and Gastric Autoimmunity

2020

Abstract Context The glycoprotein chromogranin A (CgA) is expressed by endocrine and neuroendocrine cells. High levels of serum CgA serve as markers of neuroendocrine tumors (NET), but its role in autoimmunity has not been assessed. Objective To investigate CgA utility as a marker of endocrine autoimmunity. Methods CgA serum levels were evaluated in 807 consecutive unselected participants (cross-sectional study) with the time-resolved amplified cryptate emission technology. Results Serum CgA concentrations were increased in 66%, 39%, 38%, and 24% of patients with NET, type 1 diabetes (T1D), autoimmune gastritis (AG) and autoimmune polyendocrinopathy (AP), respectively. Compared with healthy…

AdultMale0301 basic medicineendocrine systemmedicine.medical_specialtyAdolescentAutoimmune GastritisEndocrinology Diabetes and MetabolismClinical BiochemistryAutoimmunity030209 endocrinology & metabolismContext (language use)Neuroendocrine tumorsBiochemistryYoung Adult03 medical and health sciences0302 clinical medicineEndocrinologyPredictive Value of TestsInternal medicineGastrinsmedicineHumansPolyendocrinopathies AutoimmuneAgedAutoantibodiesType 1 diabetesbiologybusiness.industryBiochemistry (medical)AutoantibodyChromogranin AAutoimmune polyendocrinopathyMiddle Agedmedicine.diseaseHealthy VolunteersNeuroendocrine TumorsCross-Sectional StudiesDiabetes Mellitus Type 1030104 developmental biologyEndocrinologyROC CurveGastritisbiology.proteinChromogranin ABiomarker (medicine)FemalebusinessBiomarkersThe Journal of Clinical Endocrinology & Metabolism
researchProduct

Analysis of the gastrin-releasing peptide receptor gene in Italian patients with autism spectrum disorders

2008

The gastrin-releasing peptide receptor (GRPR) was implicated for the first time in the pathogenesis of Autism spectrum disorders (ASD) by Ishikawa-Brush et al. [Ishikawa-Brush et al. (1997): Hum Mol Genet 6: 1241-1250]. Since this original observation, only one association study [Marui et al. (2004): Brain Dev 26: 5-7] has further investigated, though unsuccessfully, the involvement of the GRPR gene in ASD. With the aim of contributing further information to this topic we have sequenced the entire coding region and the intron/exon junctions of the GRPR gene in 149 Italian autistic patients. The results of this study led to the identification of four novel point mutations, two of which, that…

AdultMalemedicine.medical_specialtyBALB 3T3 CellsAdolescentDNA Mutational AnalysisPopulationRett syndromeBiologyMiceCellular and Molecular NeuroscienceExonSettore BIO/13 - Biologia ApplicataInternal medicineGastrin-releasing peptideChlorocebus aethiopsmedicineGastrin-releasing peptide receptorAnimalsHumansPoint MutationAutistic DisorderChildautism gastrin-releasing peptide receptor signal transductionG-protein-coupled receptor association studyeducationGeneGenetics (clinical)AgedGeneticseducation.field_of_studyPoint mutationMiddle Agedmedicine.diseasePedigreeReceptors BombesinDevelopmental disorderPsychiatry and Mental healthEndocrinologyItalyCase-Control StudiesCOS CellsFemaleAmerican Journal of Medical Genetics Part B: Neuropsychiatric Genetics
researchProduct

Esophageal dysfunction and its pathogenesis in progressive systemic sclerosis

1978

In 25 patients with progressive systemic sclerosis esophageal involvement was studied prospectively by analysing subjective symptoms and radiological and manometric criteria. In all patients abnormal motility could be demonstrated by X-ray and/or manometry: radiologically in 18 (72%), manometrically in 22 (88%) cases. Dysphagia was present only in 11 patients (44%). Six patients (24%) had no subjective symptoms in spite of severe objective esophageal abnormalities. Therefore, the absence of esophageal symptoms does not exclude advanced affliction of the esophagus. To determine the pathogenesis of esophageal dysfunction the effects of 3.5 microgram/kg carbachol and of 0.6 microgram/kg pentag…

AdultMalemedicine.medical_specialtyCarbacholManometryGastroenterologySclerodermaPathogenesisEsophagusAtrophyInternal medicineDrug DiscoverymedicineHumansEsophagusGenetics (clinical)AgedPeristalsisScleroderma Systemicbusiness.industryGeneral MedicineMiddle Agedmedicine.diseaseDysphagiaSurgeryPentagastrinmedicine.anatomical_structureMolecular MedicineCarbacholFemalePentagastrinPeristalsismedicine.symptomDeglutition Disordersbusinessmedicine.drugKlinische Wochenschrift
researchProduct

Acute parathyroid hormone increase by oral peptones administration after roux-en-Y gastric bypass surgery in obese subjects: Role of phosphate in the…

2010

It is generally considered that changes in serum phosphate levels do not alter parathyroid hormone (PTH) secretion in the absence of concomitant changes in ionized serum calcium level in humans. An acute rise in PTH was shown after phosphate administration by intraduodenal gavage in rats. We aimed to study gastrin, phosphate, PTH, ionized calcium (iCa), and blood pH responses to oral peptones in morbidly obese patients before and after roux-en-Y gastric bypass (RYGB) surgery.These parameters were evaluated in response to an oral peptone load in 24 (18 male and 6 female) obese subjects before and 6 months after RYGB surgery. In 12 gastric bypass patients, we also evaluated PTH and phosphate …

AdultMalemedicine.medical_specialtyGastric BypassAdministration OralParathyroid hormonechemistry.chemical_elementAluminum HydroxideCalciumgastric bypass phosphate parathyroid hormone ionized calcium peptonesmedicine.disease_causePhosphatesJejunumYoung Adultchemistry.chemical_compoundInternal medicineGastrinsmedicineHumansPostoperative PeriodProspective StudiesGastrinCalcium metabolismGastrointestinal tractGastric bypass surgerybusiness.industryHydrogen-Ion ConcentrationPhosphateObesity MorbidJejunumEndocrinologymedicine.anatomical_structureIntestinal AbsorptionchemistryParathyroid HormonePeptonesCalciumFemaleSurgerybusinesshormones hormone substitutes and hormone antagonistsSurgery
researchProduct

Pepsinogen testing for evaluation of the success of Helicobacter pylori eradication at 4 weeks after completion of therapy.

2014

Background and objective: Pepsinogen levels in plasma are increased by inflammation in the gastric mucosa, including inflammation resulting from Helicobacter pylori infection. A decrease in pepsinogen II level has been suggested as a reliable marker to confirm the successful eradication of infection. The aim of our study was to evaluate the potential role of pepsinogens I and II, gastrin-17 and H. pylori antibodies in confirming successful eradication. Material and methods: Altogether 42 patients (25 women, 17 men), mean age 45 years (range 23–74), were enrolled. Pepsinogens I and II, gastrin-17 and H. pylori IgG antibodies were measured in plasma samples using an ELISA test (Biohit, Oyj., …

AdultMalemedicine.medical_specialtyHelicobacter pylori infectionEfficacyGastrin-17macromolecular substancesPepsinogenGastroenterologydigestive systemHelicobacter InfectionsYoung AdultAtrophyPepsinInternal medicinePepsinogen AGastrinsmedicineGastric mucosaPepsinogen CHumansEradicationAgedMedicine(all)lcsh:R5-920biologyPlasma samplesHelicobacter pyloribusiness.industryHelicobacter pyloriMiddle Agedbiology.organism_classificationmedicine.diseaseAntibodies Bacterialdigestive system diseasesmedicine.anatomical_structureTreatment OutcomeGastric MucosaAutomotive Engineeringbiology.proteinPepsinogen IIPepsinogen; Gastrin-17; Eradication; <em>Helicobacter pylori</em>; EfficacyFemaleAntibodybusinesslcsh:Medicine (General)<em>Helicobacter pylori</em>BiomarkersMedicina (Kaunas, Lithuania)
researchProduct